Life Sciences & Pharma Industrial Real Estate | Carolinas

Pharmaceutical, life sciences, and healthcare operators face operational, regulatory, and capital constraints that traditional industrial users do not.  Real estate decisions in this sector directly affect compliance, efficiency, scalability, and long-term risk - as detailed in our analysis of infrastructure and power: hidden drivers of life sciences sites.

Our services are built specifically for industrial and flex facilities that are mission-critical to operations.  We advise operators, owner-users, and investors across the full transaction lifecycle - bringing clarity, precision, and disciplined execution, while coordinating with internal legal, compliance, and quality teams to ensure enterprise alignment throughout North and South Carolina.

We represent pharmaceutical, life sciences, and healthcare tenants in the acquisition and leasing of industrial and flex properties where operational requirements drive site selection—not the other way around.

Services include:

• Industrial and flex site selection
• Market and corridor analysis across the Carolinas
• Lease structuring and negotiation
• Expansion, consolidation, and relocation strategy
• Multi-market search coordination
• Build-out feasibility and infrastructure evaluation.  Our pharmaceutical manufacturing site selection framework provides the detailed criteria operators need.

Who this Is for:

• Pharmaceutical manufacturers and distributors
• Life sciences and medical device manufacturers
• Medical and pharmaceutical supply distributors
• Cold-chain and temperature-controlled operators seeking temperature-controlled and cold-chain industrial real estate advisory - including our specialized pharma distribution facilities advisory.
• Diagnostic and specialty laboratories (non-wet lab)
• DME, home health, and specialty care operators

Most facilities range from 5,000 square feet and up, including complex, mission-critical operations.

Objective: Speed, certainty, and operational alignment - reducing friction, avoiding costly missteps, and protecting long-term flexibility. 

For pharmaceutical, life sciences, and healthcare operators, owning a facility is often a strategic business decision, not just a real estate one.

Services include:

• Acquisition and disposition of owner-occupied buildings
• SBA and owner-user financing strategy support
• Facility and expansion planning
• Lease-versus-own analysis
• Long-term operational and regulatory risk assessment

We consider capital structure, operational constraints, future growth, and enterprise governance - not just price per square foot.

We advise owners and investors on the sale and acquisition of pharmaceutical-, life sciences-, and healthcare-occupied industrial and flex assets, where income

durability is driven by operational relevance.

Services include:

• Sale of healthcare- and pharma-occupied industrial and flex assets
• Life sciences manufacturing and distribution facilities
• Cold-chain and specialized logistics properties
• Off-market and confidential transaction execution
• Buyer targeting and pricing strategy
• Use-, tenancy-, and infrastructure-driven risk analysis

Our approach emphasizes quiet execution, disciplined pricing, long-term cash flow durability, and enterprise-level alignment.

1. Operational Discovery - Understand your business, facility requirements, growth plans, and constraints.
2. Market & Use Analysis - Evaluate zoning, infrastructure, permitted use, and corridor dynamics, integrating with internal governance frameworks.
3. Strategy Development - Align real estate decisions with operational, financial, and risk objectives.
4. Execution & Negotiation - Manage diligence, negotiations, and coordination with internal teams to drive certainty and efficiency.
5. Ongoing Advisory - Support long-term planning and future decisions, maintaining alignment with enterprise needs.

• Exclusive focus on industrial and flex real estate
• Pharmaceutical, life sciences & healthcare expertise
• Carolinas-focused market knowledge
• Senior-level, hands-on execution
• Clear communication and disciplined process
• Integration with legal, compliance, and QA teams
• No volume-driven brokerage model

We are purpose-built for this segment, not generalists.

From our base in Charlotte, North Carolina, we provide advisory services across key life sciences, pharmaceutical, and industrial corridors in North and South Carolina, including:

• Charlotte Metro
• Piedmont Triad
• Research Triangle (industrial-adjacent markets)
• Greenville–Spartanburg
• Select logistics and distribution markets across the Carolinas

We expand by use case and corridor—not by chasing geography.

Owner-User Strategy for Life Sciences in the Carolinas

Gain long-term control of GMP facilities by aligning ownership, infrastructure investment, and regulatory risk in the Carolinas.

Infrastructure and Power: Hidden Drivers of Life Sciences Sites

Avoid costly missteps by vetting power, utilities, and permitting before committing to a life sciences facility.

Pharmaceutical Manufacturing Site Selection in the Carolinas

Select industrial and flex sites that support cGMP, validation, and scalable pharma manufacturing across the Carolinas and Southeast.

Life Sciences Growth Reshapes Industrial Demand in the Southeast

See how life sciences expansion is transforming industrial and flex requirements—and what it means for Southeast facility strategy.

Unlocking the Carolinas: Insights on Emerging Industrial Hubs

Leverage emerging Carolinas submarkets for lower costs, better sites, and build‑to‑suit options in industrial and healthcare logistics.

If your operation depends on your facility functioning correctly, your real estate strategy deserves specialized, enterprise-aligned attention.

Whether you’re:

• Leasing or buying industrial space
• Planning an owner-user acquisition
• Evaluating an investment or disposition
• Managing operational growth or consolidation

We bring clarity and execution to complex, high-stakes real estate decisions.

Contact us to start the conversation.